# The 67% That Changes Autoimmune Medicine - Date: 2026-04-22 - Category: Biotech & Life Sciences Kyvernas CAR-T eliminated walking aids in 67 percent of stiff person syndrome patients. If the effect holds, it would be the first treatment for the disease and the first CAR-T approved for any autoimmune condition — an inflection point for immune engineering. ---